Logo image of ALMUN.PA

MUNIC (ALMUN.PA) Stock Fundamental Analysis

EPA:ALMUN - FR0013462231 - Common Stock

0.754 EUR
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

Overall ALMUN gets a fundamental rating of 3 out of 10. We evaluated ALMUN against 26 industry peers in the Communications Equipment industry. ALMUN may be in some trouble as it scores bad on both profitability and health. ALMUN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALMUN has reported negative net income.
ALMUN had a positive operating cash flow in the past year.
ALMUN had negative earnings in 4 of the past 5 years.
In multiple years ALMUN reported negative operating cash flow during the last 5 years.
ALMUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALMUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

1.2 Ratios

ALMUN has a Return On Assets (-6.82%) which is in line with its industry peers.
ALMUN has a Return On Equity (-13.86%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.82%
ROE -13.86%
ROIC N/A
ROA(3y)-2.63%
ROA(5y)-8.15%
ROE(3y)-5.44%
ROE(5y)-448.31%
ROIC(3y)N/A
ROIC(5y)N/A
ALMUN.PA Yearly ROA, ROE, ROICALMUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1.3 Margins

The Gross Margin of ALMUN (61.40%) is better than 73.08% of its industry peers.
ALMUN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALMUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.95%
GM growth 5Y9.57%
ALMUN.PA Yearly Profit, Operating, Gross MarginsALMUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

ALMUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMUN has about the same amount of shares outstanding.
ALMUN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALMUN has an improved debt to assets ratio.
ALMUN.PA Yearly Shares OutstandingALMUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALMUN.PA Yearly Total Debt VS Total AssetsALMUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 0.13, we must say that ALMUN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.13, ALMUN is doing worse than 73.08% of the companies in the same industry.
The Debt to FCF ratio of ALMUN is 1.86, which is an excellent value as it means it would take ALMUN, only 1.86 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALMUN (1.86) is better than 76.92% of its industry peers.
ALMUN has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
ALMUN has a Debt to Equity ratio (0.41) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.86
Altman-Z 0.13
ROIC/WACCN/A
WACC5.82%
ALMUN.PA Yearly LT Debt VS Equity VS FCFALMUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

ALMUN has a Current Ratio of 1.25. This is a normal value and indicates that ALMUN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.25, ALMUN is doing worse than 80.77% of the companies in the same industry.
ALMUN has a Quick Ratio of 1.25. This is a bad value and indicates that ALMUN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALMUN (0.88) is worse than 73.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.88
ALMUN.PA Yearly Current Assets VS Current LiabilitesALMUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.31% over the past year.
The Revenue for ALMUN has decreased by -31.48% in the past year. This is quite bad
The Revenue has been decreasing by -0.61% on average over the past years.
EPS 1Y (TTM)20.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.74%
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y25.13%
Revenue growth 5Y-0.61%
Sales Q2Q%-29.55%

3.2 Future

Based on estimates for the next years, ALMUN will show a very strong growth in Earnings Per Share. The EPS will grow by 58.11% on average per year.
ALMUN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.72% yearly.
EPS Next Y150%
EPS Next 2Y58.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2Y21.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALMUN.PA Yearly Revenue VS EstimatesALMUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
ALMUN.PA Yearly EPS VS EstimatesALMUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 0 -0.2 -0.4 -0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMUN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 73.20, which means the current valuation is very expensive for ALMUN.
65.38% of the companies in the same industry are cheaper than ALMUN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ALMUN to the average of the S&P500 Index (22.69), we can say ALMUN is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 73.2
ALMUN.PA Price Earnings VS Forward Price EarningsALMUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

65.38% of the companies in the same industry are more expensive than ALMUN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALMUN indicates a rather cheap valuation: ALMUN is cheaper than 92.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.42
EV/EBITDA 9.46
ALMUN.PA Per share dataALMUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

ALMUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALMUN's earnings are expected to grow with 58.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.11%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALMUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MUNIC

EPA:ALMUN (9/5/2025, 7:00:00 PM)

0.754

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)10-02 2025-10-02
Inst Owners1.69%
Inst Owner ChangeN/A
Ins Owners26.88%
Ins Owner ChangeN/A
Market Cap6.76M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 73.2
P/S 0.52
P/FCF 2.42
P/OCF 1.28
P/B 0.63
P/tB N/A
EV/EBITDA 9.46
EPS(TTM)-0.17
EYN/A
EPS(NY)0.01
Fwd EY1.37%
FCF(TTM)0.31
FCFY41.32%
OCF(TTM)0.59
OCFY78.37%
SpS1.44
BVpS1.21
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.82%
ROE -13.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.4%
FCFM 21.68%
ROA(3y)-2.63%
ROA(5y)-8.15%
ROE(3y)-5.44%
ROE(5y)-448.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.95%
GM growth 5Y9.57%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.86
Debt/EBITDA 5.66
Cap/Depr 97.43%
Cap/Sales 19.44%
Interest Coverage N/A
Cash Conversion 678.26%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.88
Altman-Z 0.13
F-Score5
WACC5.82%
ROIC/WACCN/A
Cap/Depr(3y)373.79%
Cap/Depr(5y)531.76%
Cap/Sales(3y)17.82%
Cap/Sales(5y)20.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.74%
EPS Next Y150%
EPS Next 2Y58.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y25.13%
Revenue growth 5Y-0.61%
Sales Q2Q%-29.55%
Revenue Next Year50%
Revenue Next 2Y21.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2300%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y367.24%
OCF growth 3YN/A
OCF growth 5Y-13%